Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 134-150 , June 2011

The decision to continue or discontinue treatment: Experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months—A qualitative study

  • Erica C.G. van Geffen, Pharm.D., Ph.D.

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 30 253 7324; fax: +31 30 253 9166.
    • ,
  • Jan H.C.M. Hermsen, Pharm.D.

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    • ,
  • Eibert R. Heerdink, Ph.D.

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    • ,
  • Antoine C.G. Egberts, Professor, Ph.D., Pharm.D.

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands
    • Department of Clinical Pharmacy, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands
    • ,
  • Piet M. Verbeek-Heida, Ph.D.

      Affiliations

    • Department of Sociology and Anthropology, Faculty of Social and Behavioural Sciences, University of Amsterdam, Oudezijds Achterburgwal 185, 1012 DK Amsterdam, The Netherlands
    • ,
  • Rolf van Hulten, Pharm.D., Ph.D.

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO Box 80082, 3508 TB, Utrecht, The Netherlands

References 

  1. Depression: Management of Depression in Primary and Secondary Care (National Clinical Practice Guideline 23). London, UK: National Institute for Health and Clinical Excellence; 2004;
  2. Anxiety: Management of Anxiety (Panic Disorder, With or Without Agoraphobia, and Generalised Anxiety Disorder) in Adults in Primary, Secondary and Community Care (National Clinical Practice Guideline 22). London, UK: National Institute for Health and Clinical Excellence; 2004;amended April 2007
  3. Akincigil A, Bowblis JR, Levin C, Walkup JT, Jan S, Crystal S. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45:363–369
  4. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101–108
  5. Maddox J, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol. 1994;8:48–53
  6. Meijer WEE, Heerdink ER, Leufkens HMG, Herings RMC, Egberts ACG, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol. 2004;60:57–61
  7. Lin EHB, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67–74
  8. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105:164–172
  9. Hansen GH, Vach W, Rosholm J-U, Sondergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract. 2004;21:623–629
  10. Van Geffen ECG, Gardarsdottir H, van Hulten R, van Dijk L, Egberts ACG, Heerdink ER. Initiation of antidepressant therapy: do patients follow the GP's prescription?. Br J Gen Pract. 2009;59:81–87
  11. Van Dijk L, Heerdink ER, Somai D, et al. Patient risk profiles and practice variations in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res. 2007;7:51
  12. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403–1409
  13. Mitchell AJ. Depressed patients and treatment adherence. Lancet. 2006;367:2041–2043
  14. Donovan J. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443–455
  15. DiMatteo MR, Haskard K. Further challenges in adherence research. Measurements, methodologies, and mental care. Med Care. 2006;44:297–299
  16. Kravitz RL, Melnikow J. Medical adherence research. Time for a change in direction?. Med Care. 2004;42:197–199
  17. Urquhart J, Vrijens B. New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics. Eur J Hosp Pharm Sci. 2005;11:103–106
  18. Malpass A, Shaw A, Sharp D, et al. “Medication career” or “moral career”? The two sides of managing antidepressants: a meta-ethnography of patients' experience of antidepressants. Soc Sci Med. 2009;68:1541–1568
  19. van Geffen ECG, van Hulten R, Bouvy ML, Egberts ACG, Heerdink ER. Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother. 2008;42:218–225
  20. Badger F, Nolan P. Concordance with antidepressant medication in primary care. Nurs Stand. 2006;20:35–50
  21. Hansen HV, Kessing LV. Adherence to antidepressant treatment. Expert Rev Neurotherapeutics. 2007;7:57–62
  22. Grime J, Pollock K. Patients' ambivalence about taking antidepressants: a qualitative study. Pharm J. 2003;271:516–519
  23. Grime J, Pollock K. Information versus experience: a comparison of an information leaflet on antidepressants with lay experience of treatment. Patient Educ Couns. 2004;54:361–368
  24. Knudsen P, Hansen HE, Traulsen JM, Eskildsen K. Changes in self-concept while using SSRI antidepressants. Qual Health Res. 2002;12:932–944
  25. Strauss A, Corbin J. Basics of Qualitative Research, Grounded Theory, Procedures and Techniques. Newbury Park, CA: Sage Publications; 1990;
  26. Bollini P, Tibaldi G, Testa C, Munizza C. Understanding treatment adherence in affective disorders: a qualitative study. J Psychiatr Ment Health Nurs. 2004;11:668–674
  27. Knudsen P, Hansen EH, Eskildsen K. Leading ordinary lives: a qualitative study of younger women's perceived functions of antidepressants. Pharm World Sci. 2003;25:162–167
  28. Verbeek-Heida PM, Mathot EF. Better safe than sorry: why patients prefer to stop using selective serotonin reuptake inhibitors (SSRI) antidepressants but are afraid to do so. Results of a qualitative study of SSRI users on dilemmas concerning stopping or continuing their medication. Chronic Illn. 2006;2:133–142
  29. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000;40:173–185
  30. Demyttenaere K, Enzlin P, Dewé W, et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62(suppl 22):30–33
  31. Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24:570–575
  32. Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77:219–226

 Declaration—Funding: none; ethical approval: ethics committee approval was not required; conflicts of interest: none.

PII: S1551-7411(10)00043-4

doi: 10.1016/j.sapharm.2010.04.001

Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 134-150 , June 2011

Article Tools